Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of sustained-release oxycodone for rapid analgesia in cancer pain
ChiCTR-TIR-17012925Phase 4Not yet recruiting
- Sponsor
- Department of Head
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone and morphine in cancer pain (2 arms), sponsored by Department of Head. Primary endpoint: Proportion of patients with NRS score 3 or less during the previous 24 hours. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
oxycodonemorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR-TIR-17012925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TIR-17012925.